Showing results (201-210 of 855) with videos related to
Sort By:
Pageof 86
Pflugers Archiv : European Journal of Physiology|September 19, 2009
Angiotensin receptors as determinants of life spanPaola Cassis, Sara Conti, Giuseppe Remuzzi, et al.Expert Opinion on Emerging Drugs|November 8, 2014
Novel effective drugs for diabetic kidney disease? or not?Giorgio Gentile, Daniela Mastroluca, Piero Ruggenenti, et al.Nephron|May 18, 2026
Immunosuppressive strategies in kidney xenotransplantation with an emphasis on complement inhibitionFederica Casiraghi, Nadia Azzollini, Giuseppe Remuzzi, et al.Scientific Reports|February 20, 2026
A scanning electron microscopy-based approach to explore subpodocyte space remodeling in diabetic kidneys of mice and humansSara Conti, Ariela Benigni, Giuseppe Remuzzi, et al.Stem Cell Reviews and Reports|January 13, 2012
Multipotent mesenchymal stromal cell therapy and risk of malignanciesFederica Casiraghi, Giuseppe Remuzzi, Mauro Abbate, et al.Expert Opinion on Investigational Drugs|September 24, 2008
Investigational drugs for diabetic nephropathyMonica Cortinovis, Dario Cattaneo, Norberto Perico, et al.Journal of Nephrology|September 24, 2002
Inhibitors of the renin-angiotensin system reduce the rate of GFR decline and end-stage renal disease in patients with severe renal insufficiencyRoberto Pisoni, Rita Faraone, Piero Ruggenent, et al.Kidney International. Supplement|August 20, 2005
Prevention of progression and remission/regression strategies for chronic renal diseases: can we do better now than five years ago?Norberto Perico, Igor Codreanu, Arrigo Schieppati, et al.Trends in Molecular Medicine|February 21, 2025
Is there a place for engineered immune cell therapies in autoimmune diseases?Luca Perico, Federica Casiraghi, Ariela Benigni, et al.Clinical Journal of the American Society of Nephrology : CJASN|January 9, 2009
Hepatitis C infection and chronic renal diseasesNorberto Perico, Dario Cattaneo, Boris Bikbov, et al.Pageof 86